This is the story of how a change in marketing strategy completely transformed the fortunes of Sensodyne. Formerly a small player in a niche category, Sensodyne is now a $1bn brand, in a category it ...

Pfizer has sold 700 million shares in British consumer-healthcare business Haleon for 2.50 billion pounds, equivalent to US$3.05 billion, it said in a statement. The U.S. drugmaker said Wednesday that ...